Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

Growth effects of insulin and insulin analogues

(2011) Juergen Sandow   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

The Association between Diabetes, Insulin Use, and Colorectal Cancer among Whites and African Americans

(2009) L. C. Vinikoor et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Insulin Glargine and Cancer—An Unsubstantiated Allegation

(2009) Satish K. Garg et al.   Diabetes Technology & Therapeutics

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

(2009) Doron Weinstein et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

(2009) P. D. Home et al.   DIABETOLOGIA

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

(2009) J. Rosenstock et al.   DIABETOLOGIA

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study

(2009) J. Rosenstock et al.   DIABETOLOGIA

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

(2009) J. M. Jonasson et al.   DIABETOLOGIA

No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

(2009) A. Dejgaard et al.   DIABETOLOGIA

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2009) H. M. Colhoun et al.   DIABETOLOGIA

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

(2009) L. G. Hemkens et al.   DIABETOLOGIA

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines

(2009) Ashish Shukla et al.   ENDOCRINE-RELATED CANCER

Insulin glargine and malignancy: an unwarranted alarm

(2009) Stuart J Pocock et al.   LANCET

Cancer as an endocrine problem

(2008) Jeff M.P. Holly et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Insulin Therapy and Colorectal Adenoma Risk Among Patients with Type 2 Diabetes Mellitus: A Case-Control Study in Korea

(2008) Yong Woo Chung et al.   DISEASES OF THE COLON & RECTUM

Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus

(2008) Bethany B. Barone   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION